Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Sanofi Q2 2024 Adj EPS $0.93 Beats $0.86 Estimate, Sales $11.568B Beat $11.366B Estimate

Author: Benzinga Newsdesk | July 25, 2024 01:40am
Sanofi (NASDAQ:SNY) reported quarterly earnings of $0.93 per share which beat the analyst consensus estimate of $0.86 by 8.26 percent. This is a 2 percent decrease over earnings of $0.95 per share from the same period last year. The company reported quarterly sales of $11.568 billion which beat the analyst consensus estimate of $11.366 billion by 1.78 percent. This is a 6.52 percent increase over sales of $10.860 billion the same period last year.

Posted In: SNY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist